SOLX Gold Shunt for Refractory Glaucoma
Conditions
Glaucoma | Glaucoma, Open Angle
What is the purpose of this trial?
To establish the clinical performance of the SOLX Gold Shunt for its ability to reduce intraocular pressure (IOP) in eyes with refractory glaucoma where medical and conventional surgical treatments have failed.
Participation Guidelines
- Age:
- 21 Years and older
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- SOLX, Inc.
- Dates:
- January 2011
- Last Updated:
- July 9, 2012
- Study HIC#:
- 1008007298
Clinicaltrials.gov ID: NCT01282346
Investigators
James Tsai, MD, MBA
Principal Investigator
Nils Loewen, MD, PhD
Principal Investigator
